RxDoctor Payments Data

Nanette Joyce, DO

Physical Medicine & Rehabilitation · Sacramento, CANPI 1124241302

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,750 of the $55,798 with a category attached, or 65.9%. Biogen accounts for 99.8% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $55,468 and has fallen 99.7% since, to $143 in 2024. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,798in general payments, 2019–2025

Across 64 payments — averaging $871.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$56K
  • Advanced Respiratory, Inc$123
$181,517in research payments, 2019–2025

Across 26 payments — averaging $6981.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$76K
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$69K
  • Genentech, Inc.$31K
  • Tanabe Pharma America, Inc.$6K

What the payments were for

  • Consulting fees$8,82016%
  • Speaking & faculty fees$36,75066%
  • Travel & lodging$9,04716%
  • Food & beverage$9212%
  • Education$2600%

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen61$55,675
Advanced Respiratory, Inc3$123

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,798 in reported general payments places this provider in the 95th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California

Medicare billing

Part B allowed, 2024
$59,422
Medicare patients
302
Services billed
781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EvrysdiRisdiplam90$2,395,517
Radicava OrsEdaravone12$158,530
Glycopyrrolate11$1,635
Baclofen12$322
Amitriptyline Hcl14$148

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →